earnings
saveVera Therapeutics, Inc. earnings
community read0 votes
Anticipated earnings call for Vera Therapeutics, Inc. ($VERA).
view source ↗Data sources
Found something off?
related news · 8
- statSTAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
- endpointsFDA approves Takeda, Protagonist drug for rare blood disorder
- fda pressFDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
- biospaceVera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
- biopharma diveCapricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
- biospaceZealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
- fiercebiotechZealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
- biopharma diveSilence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
comments(0)
5-min edit window · permanent after that